AID Life Science Holdings Limited provided earnings guidance for the three months ended 31 March 2019. For the three months, the Group is expected to record a significant decrease in loss for the three months ended 31 March 2019 as compared to that for the three months ended 31 March 2018, which was mainly attributable to significant decrease in fair value loss recognised as a result of fair value change of financial assets at fair value through profit or loss during the Period.